Sector Watch: Healthcare - May 07 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $103.00 +0.65 0.64% | XBI: $88.50 +1.13 1.29% | Updated May 07, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| TTPH Tetraphase Pharmaceuticals $183.3M |
3.64+0.41 1.8 M 2.0x |
13% | ||
| SRNE Sorrento Therapeutics $640.8M |
7.15+0.70 2.7 M |
11% | ||
| OSUR OraSure Technologies $1.0B |
15.78+1.32 1.1 M 1.8x |
9% | ||
| ITCI Intra-Cellular Therapies $1.1B |
19.64+1.64 417.3 K |
9% | ||
| LXRX Lexicon Pharmaceuticals $951.5M |
9.50+0.75 703.2 K |
9% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| XENT Intersect ENT $1.1B |
37.40-4.30 2.3 M 10.6x |
-10% | ||
| AGEN Agenus $324.5M |
3.32-0.36 2.4 M 1.8x |
-10% | ||
| EVFM Evofem BioSciences $126.0M |
7.40-0.79 18.2 K |
-10% | ||
| EYES Second Sight Medical Products $82.2M |
1.53-0.12 411.9 K 2.0x |
-7% | ||
| XRAY52WL DENTSPLY SIRONA $10.5B |
46.92-3.07 5.2 M 2.3x |
-6% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Agenus to Present at Deutsche Bank?s 43rd Annual Health Care Conference in Boston [prnewswire.com]Agenus to Present at Deutsche Bank's 43rd Annual Health Care Conference in Boston [prnewswire.com]
Dentsply Sirona Reports First Quarter 2018 Results [globenewswire.com]
Dr. Robert J. Hariri Honored At Unite to Cure, The 4th International Vatican Conference, With The [prnewswire.com]
Dr. Robert J. Hariri Honored At Unite to Cure, The 4th International Vatican Conference, With The 2018 Pontifical Key Innovation Award [prnewswire.com]
OraSure Technologies Appoints New Chief Financial Officer [globenewswire.com]
Lexicon Pharmaceuticals Announces Publication of New XERMELO® (Telotristat Ethyl) Data in Clinical Therapeutics [globenewswire.com]
Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences [globenewswire.com]
Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call | Business Wire [businesswire.com]
Hercules Capital Announces First Quarter 2018 Financial Results and Quarterly Distribution of $0.31 per Share | Business Wire [businesswire.com]
Rhinitis: Epidemiology Overview and Insights to 2024 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights [globenewswire.com]
Parkinson's Market Intelligence Review and Insights 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer [globenewswire.com]
Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update [globenewswire.com]
Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update Nasdaq:LXRX [globenewswire.com]
OraSure Announces 2018 First Quarter Financial Results [globenewswire.com]
Intersect ENT Reports First Quarter 2018 Results | Business Wire [businesswire.com]
Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc, Neos Therapeutics, and Tech Data with Renewed Outlook ? Fundamental Analysis, Calculating Forward Movement [globenewswire.com]
Incyte Reports 2018 First-Quarter Financial Results and Updates on Key Clinical Programs | Business Wire [businesswire.com]
Checkpoint Inhibitors for Treating Cancer Market Report 2018-2028 - Visiongain Report [prnewswire.com]
AgenTus Therapeutics to Present on Novel TCR Platform and Progress at PEGS Summit in Boston, MA [prnewswire.com]
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders [globenewswire.com]
Recent Analysis Shows Morningstar, Tactile Systems Technology, Allete, Tetraphase Pharmaceuticals, Magellan Health, and Ambarella Market Influences ? Renewed Outlook, Key Drivers of Growth [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
